Shares of Simulations Plus (NASDAQ:SLP) have received an average broker rating score of 1.00 (Strong Buy) from the one brokers that provide coverage for the stock, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy recommendation.
Analysts have set a 12-month consensus price objective of $18.75 for the company and are anticipating that the company will post $0.13 earnings per share for the current quarter, according to Zacks. Zacks has also assigned Simulations Plus an industry rank of 63 out of 265 based on the ratings given to related companies.
Get Simulations Plus alerts:
Several research analysts have commented on the company. ValuEngine raised Simulations Plus from a “buy” rating to a “strong-buy” rating in a research report on Monday. BidaskClub downgraded Simulations Plus from a “strong-buy” rating to a “buy” rating in a research report on Wednesday. Finally, Zacks Investment Research raised Simulations Plus from a “sell” rating to a “hold” rating in a research report on Wednesday, January 24th.
In other news, Chairman Walter S. Woltosz sold 18,500 shares of the business’s stock in a transaction that occurred on Tuesday, March 27th. The stock was sold at an average price of $14.54, for a total transaction of $268,990.00. Following the sale, the chairman now directly owns 5,466,408 shares in the company, valued at $79,481,572.32. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO John Robert Kneisel sold 2,991 shares of the business’s stock in a transaction that occurred on Friday, April 20th. The shares were sold at an average price of $17.64, for a total value of $52,761.24. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 58,491 shares of company stock worth $938,356. 33.45% of the stock is currently owned by company insiders.
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Bank of Montreal Can bought a new stake in shares of Simulations Plus during the fourth quarter valued at approximately $104,000. The Manufacturers Life Insurance Company grew its position in Simulations Plus by 142.2% in the fourth quarter. The Manufacturers Life Insurance Company now owns 9,378 shares of the technology company’s stock valued at $151,000 after acquiring an additional 5,506 shares during the period. Strs Ohio grew its position in Simulations Plus by 196.9% in the fourth quarter. Strs Ohio now owns 9,500 shares of the technology company’s stock valued at $152,000 after acquiring an additional 6,300 shares during the period. Citigroup Inc. grew its position in Simulations Plus by 1,154.8% in the first quarter. Citigroup Inc. now owns 11,670 shares of the technology company’s stock valued at $172,000 after acquiring an additional 10,740 shares during the period. Finally, Algert Global LLC bought a new stake in Simulations Plus in the fourth quarter valued at $175,000. Institutional investors and hedge funds own 32.68% of the company’s stock.
Shares of NASDAQ SLP opened at $19.00 on Wednesday. The company has a market capitalization of $329.19 million, a price-to-earnings ratio of 55.88 and a beta of -0.56. Simulations Plus has a 12 month low of $19.00 and a 12 month high of $19.20.
Simulations Plus (NASDAQ:SLP) last issued its quarterly earnings results on Monday, April 9th. The technology company reported $0.11 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.11. The company had revenue of $7.36 million for the quarter, compared to the consensus estimate of $7.37 million. Simulations Plus had a return on equity of 26.19% and a net margin of 30.65%. equities analysts anticipate that Simulations Plus will post 0.4 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 2nd. Stockholders of record on Wednesday, April 25th were given a dividend of $0.06 per share. This represents a $0.24 dividend on an annualized basis and a dividend yield of 1.26%. The ex-dividend date was Tuesday, April 24th. Simulations Plus’s dividend payout ratio is presently 70.59%.
Simulations Plus Company Profile
Simulations Plus, Inc develops drug discovery and development software for mechanistic modeling and simulation worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), and pharmacodynamics of drugs administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments, which measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments.
Get a free copy of the Zacks research report on Simulations Plus (SLP)
For more information about research offerings from Zacks Investment Research, visit Zacks.com